Q4 2022 Holdings
Filed 2023-02-13 | 36 holdings | $194.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| QQQ Jan3 270.0 PPut | Listed Option | 46090E953 | $39.9M | 150,000 | 20.6% |
| Veradigm ORD(MDRX) | Equity | 01988P108 | $12.6M | 715,000 | 6.5% |
| Viatris ORD(VTRS) | Equity | 92556V106 | $10.9M | 975,000 | 5.6% |
| SPY Jan3 380.0 PPut | Listed Option | 78462F953 | $9.6M | 25,000 | 4.9% |
| Phreesia ORD(PHR) | Equity | 71944F106 | $9.2M | 285,000 | 4.7% |
| Cerus ORD(CERS) | Equity | 157085101 | $9.1M | 2,500,000 | 4.7% |
| Collegium Pharmaceutical ORD(COLL) | Equity | 19459J104 | $9.0M | 387,000 | 4.6% |
| Streamline Health Solutions ORD | Equity | 86323X106 | $7.8M | 4,930,882 | 4.0% |
| Alkermes ORD(ALKS) | Equity | G01767105 | $7.2M | 275,000 | 3.7% |
| Angiodynamics ORD(ANGO) | Equity | 03475V101 | $6.7M | 490,000 | 3.5% |
| BDX Jan3 260.0 PPut | Listed Option | 075887959 | $6.4M | 25,000 | 3.3% |
| Biogen ORD(BIIB) | Equity | 09062X103 | $5.5M | 20,000 | 2.9% |
| Ascendis Pharma ADR REP ORD(ASND) | Equity | 04351P101 | $5.5M | 45,000 | 2.8% |
| Lantheus Holdings ORD(LNTH) | Equity | 516544103 | $5.4M | 105,000 | 2.8% |
| Tenet Healthcare ORD(THC) | Equity | 88033G407 | $4.6M | 95,000 | 2.4% |
| SI Bone ORD(SIBN) | Equity | 825704109 | $4.5M | 330,000 | 2.3% |
| Pacira Biosciences ORD(PCRX) | Equity | 695127100 | $3.9M | 100,000 | 2.0% |
| Neogen ORD(NEOG) | Equity | 640491106 | $3.8M | 250,000 | 2.0% |
| Rigel Pharmaceuticals ORD(RIGLUSD) | Equity | 766559603 | $3.5M | 2,300,000 | 1.8% |
| Inmode ORD(INMD) | Equity | M5425M103 | $3.2M | 90,000 | 1.7% |
| Tactile Systems Technology ORD(TCMD) | Equity | 87357P100 | $2.9M | 255,000 | 1.5% |
| Merck & Co ORD(MRK) | Equity | 58933Y105 | $2.8M | 25,000 | 1.4% |
| Turning Point Brands ORD(TPB) | Equity | 90041L105 | $2.7M | 125,000 | 1.4% |
| Docgo ORD(DCGO) | Equity | 256086109 | $2.7M | 375,000 | 1.4% |
| Sanofi ADR REP 1 1/2 ORD(SNY) | Equity | 80105N105 | $2.4M | 50,000 | 1.2% |
| Atricure ORD(ATRC) | Equity | 04963C209 | $2.2M | 50,000 | 1.1% |
| Ironwood Pharma CL A ORD(IRWD) | Equity | 46333X108 | $2.2M | 175,000 | 1.1% |
| Fennec Pharmaceuticals ORD(FENC) | Equity | 31447P100 | $2.0M | 213,000 | 1.1% |
| Radnet ORD(RDNT) | Equity | 750491102 | $1.9M | 100,000 | 1.0% |
| Plexus ORD(PLXS) | Equity | 729132100 | $1.6M | 15,500 | 0.8% |
| ICU Medical ORD(ICUI) | Equity | 44930G107 | $787.4K | 5,000 | 0.4% |
| Somalogic CL A ORD(SLGCUSD) | Equity | 83444K105 | $627.5K | 250,000 | 0.3% |
| Maxcyte ORD(MXCT) | Equity | 57777K106 | $546.0K | 100,000 | 0.3% |
| Caredx ORD(CDNA) | Equity | 14167L103 | $342.3K | 30,000 | 0.2% |
| Nanostring Technologies ORD(NSTGEUR) | Equity | 63009R109 | $239.1K | 30,000 | 0.1% |
| Somalogic EQY Warrant(SLGCUSD)Call | Warrant | 83444K105 | $50.2K | 20,000 | 0.0% |